Gilead Sciences, Inc.

  GILD 56.38 +0.61 (+1.1%)

Gilead is a biopharmaceutical company involved in discovering, developing, and advertising treatments of life-threatening infectious diseases. The company's primary focus is on antiviral, cardiovascular, and respiratory treatments.

What do YOU think?

Use the icons below to select how you think GILD will perform over the next 90 days. Just like you'd suspect, red is bad and green is good.

    Sentiment
  • Spc

    Sentiment

  • High

    Activity

Have something to say?

Register for Piqqem
and give us your take on Gilead Sciences, Inc.